Related Subjects:
|Analgesia
|Sedation and Analgesia on ITU
|Codeine
|Dihydrocodeine
|Diamorphine
|Morphine
|Opiates
โ ๏ธ Safety notes:
- Caution in elderly or those with renal, hepatic, or cardiac impairment โ accumulation can cause sedation, delirium, or coma.
- Codeine is a pro-drug metabolised to morphine by CYP2D6.
- 240 mg codeine โ 30 mg morphine.
๐ About
Always check the BNF link here.
- ๐ Weak opioid analgesic (step 2 of WHO analgesic ladder).
- ๐ง Can cause confusion and delirium in elderly patients.
- โ ๏ธ Genetic variation in CYP2D6 metabolism โ some patients are ultra-rapid metabolisers (risk of toxicity) while others are poor metabolisers (poor efficacy).
โก Mechanism of Action
- Acts as an agonist at opioid receptors (ฮผ-opioid receptor).
- Most of its analgesic effect occurs after conversion to morphine via hepatic metabolism.
- Also has central anti-tussive and peripheral anti-diarrhoeal effects.
๐ฉบ Indications & Dosing โ Codeine (verify with BNF/datasheet)
| Indication |
Details |
| ๐ค Pain Relief |
Adults: 30โ60 mg PO/IM every 4 h PRN (max 240 mg/24 h)
Elderly/renal impairment: 15 mg PO/IM every 4 h PRN
๐ Often used in combination (e.g. Co-codamol = codeine + paracetamol)
โ ๏ธ Not for long-term use (risk: dependence & constipation)
|
| ๐จ Antitussive (cough suppressant) |
Rarely used now due to risk profile
(historical use at lower doses)
|
| ๐ฉ Anti-diarrhoeal |
Rarely used for this purpose in modern practice
|
๐ Interactions
- โ ๏ธ Avoid with MAOIs (risk of serotonin syndrome, hypertensive crisis).
- โฌ๏ธ Sedation risk when combined with alcohol, benzodiazepines, or other CNS depressants.
- Metabolism altered by CYP2D6 inhibitors (e.g. fluoxetine, paroxetine) and inducers.
โ ๏ธ Cautions
- ๐ต Elderly โ high risk of delirium, sedation, constipation.
- ๐ง Renal impairment (accumulation of active metabolites).
- ๐ซ Heart failure, hypotension.
- ๐ซ Asthma or COPD (respiratory depression risk).
- ๐คฐ Pregnancy/breastfeeding โ avoid (toxic morphine levels may pass to neonate, especially if mother is ultra-rapid metaboliser).
๐ซ Contraindications
- Acute respiratory depression.
- Paralytic ileus.
- Known hypersensitivity to opioids.
- Children post-tonsillectomy/adenoidectomy (risk of fatal respiratory depression in ultra-rapid metabolisers).
๐ฅ Side Effects
- ๐ซ Respiratory depression, coma (reverse with naloxone if severe).
- ๐ง Sedation, dizziness, delirium, hallucinations.
- ๐ Miosis (pinpoint pupils).
- ๐ฉ Constipation (always consider laxative co-prescription).
- ๐คข Nausea, vomiting.
- ๐ฆ Dependence, tolerance, and withdrawal symptoms with chronic use.
- Rare: hypersensitivity reactions, pancreatitis, urinary retention.
๐ References